Chronic kidney disease trials recruiting in Virginia

All Chronic kidney disease trials nationally

Cities in Virginia

Recruiting trials in Virginia

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Virginia: Norfolk
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington, Manassas, Newport News, Richmond
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Woodbridge
• A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
  NCT07223502 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Vienna
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Norfolk
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Virginia: Richmond
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington, Norfolk
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Virginia: Chesapeake, Fishersville, Mechanicsville, Midlothian
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Chesapeake, Fairfax, Hampton, Norfolk
• Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
  NCT05880537 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Norfolk
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Charlottesville, Manassas, Newport News, Salem
• Incremental Hemodialysis: The TwoPlus Trial
  NCT05828823 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• Kidney Function in People With Cystic Fibrosis in the Era of HEMT
  NCT06595420 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
  NCT06190717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female) · Virginia: Arlington, Roanoke, Virginia Beach
• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
  NCT06422871 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Norfolk
• Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
  NCT06516653 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Virginia: Roanoke
• Transformative Research in Diabetic Nephropathy
  NCT02986984 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Virginia: Charlottesville